Martha Donoghue

16PUBLICATIONS
90CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsAvionics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 02, 2026
Considerations for Clinical Trial Design in Relapsed and Refractory Osteosarcoma: An FDA Symposium.

Kristin M Wessel, Katherine A Janeway, Lara E Davis

|May 06, 2025
Dosage Optimization of Pediatric Oncology Products: Our Patients Deserve Better.

Kristin M Wessel, Nicole Drezner, Stacy S Shord

|Jan 14, 2025
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.

Sonia Singh, Diana Bradford, Somak Chatterjee

|Feb 15, 2024
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium.

Jason Fangusaro, Robert A Avery, Michael J Fisher

|Aug 25, 2023
FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum.

Sonia Singh, Diana Bradford, Xiaoxue Li

|Aug 23, 2023
FDA Approval Summary: Dabrafenib in Combination with Trametinib for BRAFV600E Mutation-Positive Low-Grade Glioma.

Michael I Barbato, Jeannette Nashed, Diana Bradford

Pageof 3

Frequent Collaborators

5 joint publications

Harpreet Singh

5 joint publications

Nicole Drezner

5 joint publications

Richard Pazdur

4 joint publications

Lola Fashoyin-Aje